Home › Overweight › Arizona › Phoenix

Pag-aaral pangklinika para sa Overweight sa Phoenix, AZ

Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Phoenix. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Nagre-recruitPhase 3

Absolute Clinical Research, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07794579

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3

Synexus Clinical Research US, Inc., Phoenix
Medical Advancement Centers of Arizona, Phoenix

Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Nagre-recruitPhase 3

Elite Clinical Studies, LLC, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07353931

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Nagre-recruitPhase 3

Research Site, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Nagre-recruitPhase 3

RIO Clinical Trials - Phoenix, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Nagre-recruitPhase 3

AURORA-2 Clinical Site, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 3

AURORA-1 Clinical Site, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Nagre-recruitPhase 2

Helios Clinical Research - Phoenix, Phoenix

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo

ACCOMPLISH-2 Research Site, Phoenix

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Nagre-recruitPhase 2

Synexus Clinical Research US, Inc., Phoenix

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Nagre-recruitPhase 4

Medical Dermatology Specialists, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Nagre-recruitPhase 3

Kailera Clinical Site, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

Nagre-recruitObservasyonal na pag-aaral

Exponent Phoenix, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07776678

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Nagre-recruitPhase 3

ACCOMPLISH-1 Research Site, Phoenix

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Nagre-recruitPhase 3

The University of Arizona College of Medicine- Phoenix, Phoenix

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT06499857

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa Phoenix

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.